Blossom BioScience
- Company typePrivate
- Founded2020
- HeadquartersSanta Clara, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
Blossom BioScience firmographics
Firmographics- Name
- Blossom BioScience
- Legal name
- Blossom BioScience LLC
- Website
- https://blossombioscience.com
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Where Blossom BioScience is headquartered
LocationHeadquarters
- HQ city
- Santa Clara
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Blossom BioScience business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales
Revenue model
- Off-the-Shelf Reporter Cell Lines: Sale of pre-made luciferase reporter cell lines (BxPC3-Luc, K562-Luc, Jurkat-Luc, OE21-Luc) as frozen cryovials containing 5 million cells each. Each vial is sold as a one-time purchase with pricing ranging from $1190 per vial for BxPC3-Luc. Revenue is recognized upon shipment.
- Custom Cell Line Development Services: Professional services for generating stable cell lines tailored to customer specifications. Includes options for monoclonal or polyclonal cell lines, custom gene modifications, and specific reporter gene insertions (luciferase, GFP, mCherry). Revenue is project-based and requires direct consultation.
- Cell Biology Assay Services: Fee-for-service cytotoxicity and cell viability assays including T cell dependent cytotoxicity (TDCC), NK cell mediated cytotoxicity (NKCC), antibody dependent cytotoxicity (ADCC), cell proliferation assays, IC50 studies, WesternBlots, and ELISA services.
- Cell Culture and Banking Services: Services for cell culturing, expansion, generation of master and working cell banks, cryogenic preservation, viability testing, contamination testing, and cell line authentication performed as contracted services.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Standard Luciferase Reporter Cell Lines - $1190 per cryovial (5 million cells) |
| Other | Pay-as-you-go | Custom Cell Line Generation - Quote-based pricing |
| Other | Pay-as-you-go | Assay Services - Quote-based pricing |
Go-to-market motion2 records
Distribution channels2 records
Marketing channels3 records
Blossom BioScience product offering
Product offeringCore offering
Blossom BioScience is a contract research laboratory that develops, manufactures, and sells luciferase reporter cell lines and provides custom cell line generation, cell banking, and cytotoxicity assay services. It sells off-the-shelf catalog products (BxPC3-Luc, OE21-Luc, Jurkat-Luc, K562-Luc) directly through its e-commerce site and delivers project-based custom research services to pharmaceutical, biotechnology, and academic institutions.
Product overview
Blossom BioScience is a biotech company specializing in cell line development and advanced assay services for research use. The core product portfolio consists of off-the-shelf luciferase reporter cell lines (BxPC3-Luc, OE21-Luc, Jurkat-Luc, K562-Luc) engineered via lentiviral transduction with firefly luciferase (Luc2) and puromycin resistance. These cell lines support cytotoxicity, viability, proliferation assays, and in vivo imaging applications. The service offering includes Stable Cell Line Generation (using third-generation lentivural transduction with options for luciferase, GFP, mCherry reporters), Cell Culture Service and Banking (mammalian cell culturing, expansion, cryogenic preservation, STR authentication), and Cytotoxicity and Cell Viability Services (TDCC, NKCC, ADCC assays, IC50 studies). Complementary resources include Cell Culture Protocols and a Cell Culture Medium Comparison Tool for formulation analysis.
Differentiator
Problem solved
Functional benefit
Products and services
- BxPC3-Luc Off-the-shelf luciferase reporter cell line derived from human pancreatic adenocarcinoma BxPC3 cells, expressing codon-optimized firefly luciferase (Luc2) under an EF-1 alpha promoter with puromycin resistance for stable selection. Sold as 1 cryovial of 5 million frozen cells at $1,190 per vial, intended for cytotoxicity assays, viability studies, and in vivo bioluminescence imaging in cancer and drug discovery research.
- OE21-Luc Off-the-shelf luciferase reporter cell line derived from human esophageal carcinoma OE-21 cells, engineered with a lentiviral vector encoding firefly luciferase (Luc2) and puromycin resistance. Sold as 1 cryovial of 5 million frozen cells at $1,190 per vial, intended for cytotoxicity and proliferation assays in oncology research.
- Jurkat-Luc Off-the-shelf luciferase reporter cell line derived from Jurkat E6-1 T-lymphoblast cells, expressing firefly luciferase (Luc2) via an EF-1 alpha promoter with puromycin selection. Sold as 1 cryovial of 5 million frozen cells at $1,190 per vial, suitable for immune effector cell assays (TDCC, NKCC, ADCC) and in vivo imaging applications.
- K562-Luc Off-the-shelf luciferase reporter cell line derived from chronic myelogenous leukemia K562 cells, expressing Luc2 firefly luciferase under an EF-1 alpha promoter with puromycin resistance. Sold as 1 cryovial of 5 million frozen cells at $1,190 per vial, validated for 15 passages and verified mycoplasma-free via PCR; intended for cytotoxicity assays and in vivo imaging.
- Stable Cell Line Generation Service Custom stable cell line development service using third-generation lentiviral transduction systems, supporting both polyclonal and monoclonal outputs with optional reporter genes including luciferase, GFP, and mCherry. Includes lentivirus packaging, gene editing, and process optimization steps; delivered on a project basis with quote-based pricing for pharmaceutical, biotech, and academic customers.
- Cell Culture Service and Banking Contracted mammalian cell culture and banking service covering cell culturing, expansion, master and working cell bank generation, cryogenic preservation, viability testing, contamination (mycoplasma) testing, and STR-based cell line authentication. Priced per project and intended for research institutions, biotech, and pharma customers needing outsourced cell banking workflows.
- Cytotoxicity and Cell Viability Services Fee-for-service in vitro cytotoxicity and viability assays including T cell-dependent cellular cytotoxicity (TDCC), NK cell-mediated cytotoxicity (NKCC), antibody-dependent cellular cytotoxicity (ADCC), cell proliferation assays, IC50/EC50 studies, LDH release, and caspase activity measurements. Delivered on a project basis to researchers in immuno-oncology, antibody therapeutic development, and drug discovery.
Quantifiable outcome
- Cell line viability guaranteed for 60 days after shipment when properly handled
Companies that use Blossom BioScience
Customer profileSegments2 records
Ideal customer profiles2 records
Blossom BioScience technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Blossom BioScience partnerships and signals
Strategic signalRecent moves5 records
Expansion highlights5 records
Blossom BioScience competitors and assessment
Company assessmentBroad incumbents
- ATCC: Global, established biological resource repository offering authenticated cell lines and related services. Operates far more broadly than Blossom but overlaps in the supply of validated research cell lines.
- Promega Corporation: Major life science tools provider with a broad portfolio of reporter cell lines, luciferase assays, and cell-based assay reagents. Larger and more diversified, but addresses overlapping customer workflows in cytotoxicity and reporter gene assays.
- Bio-Techne: Diversified life science tools company with cell biology reagents, assay kits, and custom services (including through its R&D Systems and ProteinSimple brands) — a much larger incumbent serving overlapping customers in cell-based research.
Direct peers
- Imanis Life Sciences: Provides reporter cell lines, in vivo imaging services, and custom cell line generation for immuno-oncology and cell therapy research, directly competing with Blossom's reporter cell lines and assay services.
- Cell Biolabs: Offers cell-based assay kits, reporter cell lines, and custom cell line development services for life science research, serving a similar academic and biotech customer base as Blossom.
- SignaGen Laboratories: Specializes in custom lentivirus production, stable cell line engineering, and reporter cell lines for research, overlapping Blossom's core lentiviral transduction and stable cell line development offerings.
- BPS Bioscience: San Diego-based CRO and reagent supplier specializing in cell lines, recombinant proteins, and cell-based assay services for drug discovery, including reporter cell lines and lentivirus-based tools that directly overlap Blossom BioScience's offering.
- GenTarget: Developer and supplier of custom and catalog reporter cell lines, stable cell line generation services, and lentivirus products — a near-direct competitor to Blossom's catalog and custom service portfolio.
Emerging players
- Creative Diagnostics: Supplies custom and catalog cell lines, recombinant proteins, and assay development services for research use, competing in the same niche as Blossom across catalog reagents and bespoke cell line work.
- ReachBio Research Services: Specialty CRO offering cell-based assay services including cytotoxicity and proliferation assays, with a customer base of pharma and biotech researchers overlapping Blossom's assay service offering.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Blossom BioScience social profiles
Digital presenceBlossom BioScience financial estimates
Financial estimateRevenue estimate
Valuation estimate
Blossom BioScience leadership team
Management profileNumber of profiles
Profiles1 record
Blossom BioScience funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Blossom BioScience M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Blossom BioScience
What does Blossom BioScience do?
Blossom BioScience is a contract research laboratory that develops, manufactures, and sells luciferase reporter cell lines and provides custom cell line generation, cell banking, and cytotoxicity assay services. It sells off-the-shelf catalog products (BxPC3-Luc, OE21-Luc, Jurkat-Luc, K562-Luc) directly through its e-commerce site and delivers project-based custom research services to pharmaceutical, biotechnology, and academic institutions.
Is Blossom BioScience a public or private company?
Blossom BioScience is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Blossom BioScience founded?
Blossom BioScience was founded in 2020. It employs 11 to 50 people.
Where is Blossom BioScience based?
Blossom BioScience is headquartered in Santa Clara, United States, in the North America region.
How does Blossom BioScience make money?
Four revenue lines are on record. Off-the-Shelf Reporter Cell Lines are the primary driver. The others are custom Cell Line Development Services, cell Biology Assay Services and cell Culture and Banking Services.
Who are Blossom BioScience's main competitors?
Broad incumbents on record are ATCC, Promega Corporation and Bio-Techne. Direct peers are Imanis Life Sciences, Cell Biolabs, SignaGen Laboratories, BPS Bioscience and GenTarget. Emerging players are Creative Diagnostics and ReachBio Research Services.
Does Blossom BioScience have an API?
No public API is recorded for Blossom BioScience.